APA (7th ed.) Citation

Maurer, B., Mirkina, I., Mayer, J., Landlinger, C., Schinagl, A., Thiele, M., & Kerschbaumer, R. (2022). 1059 ON203: A new antibody targeting the oxidized form of macrophage migration inhibitory factor (oxMIF) exerts antitumorigenic activity and modulates the tumor microenvironment. Journal for immunotherapy of cancer, 10(Suppl 2), A1101. https://doi.org/10.1136/jitc-2022-SITC2022.1059

Chicago Style (17th ed.) Citation

Maurer, Barbara, Irina Mirkina, Julia Mayer, Christine Landlinger, Alexander Schinagl, Michael Thiele, and Randolf Kerschbaumer. "1059 ON203: A New Antibody Targeting the Oxidized Form of Macrophage Migration Inhibitory Factor (oxMIF) Exerts Antitumorigenic Activity and Modulates the Tumor Microenvironment." Journal for Immunotherapy of Cancer 10, no. Suppl 2 (2022): A1101. https://doi.org/10.1136/jitc-2022-SITC2022.1059.

MLA (9th ed.) Citation

Maurer, Barbara, et al. "1059 ON203: A New Antibody Targeting the Oxidized Form of Macrophage Migration Inhibitory Factor (oxMIF) Exerts Antitumorigenic Activity and Modulates the Tumor Microenvironment." Journal for Immunotherapy of Cancer, vol. 10, no. Suppl 2, 2022, p. A1101, https://doi.org/10.1136/jitc-2022-SITC2022.1059.